Mid1 is associated with androgen-dependent axonal vulnerability of motor neurons in spinal and bulbar muscular atrophy. [PDF]
Ogura Y +5 more
europepmc +1 more source
Editorial Comment to Castration-resistant prostate cancer diagnosed during leuprorelin treatment for spinal and bulbar muscular atrophy. [PDF]
Pennuto M, Montopoli M, Rinaldi C.
europepmc +1 more source
Restoring early postnatal synaptic dysregulation rescues motor neuron degeneration in a mouse model of Spinal and Bulbar Muscular Atrophy. [PDF]
Hirunagi T +11 more
europepmc +1 more source
Long-term effects of the gait treatment using a wearable cyborg hybrid assistive limb in a patient with spinal and bulbar muscular atrophy: a case report with 5 years of follow-up. [PDF]
Iijima K +6 more
europepmc +1 more source
PROTACs therapeutically target the polyglutamine androgen receptor in spinal and bulbar muscular atrophy models. [PDF]
Sangotra A +7 more
europepmc +1 more source
Diagnostic support for selected neuromuscular diseases using answer-pattern recognition and data mining techniques: a proof of concept multicenter prospective trial [PDF]
core +1 more source
Nucleic Acid-Based Therapeutic Approach for Spinal and Bulbar Muscular Atrophy and Related Neurological Disorders. [PDF]
Hirunagi T +3 more
europepmc +1 more source
Persistent Jaw Drop Following Botulinum Injection as the Initial Clinical Manifestation of Spinal and Bulbar Muscular Atrophy. [PDF]
Ju W, Min YG, Ahn SW, Sung JJ.
europepmc +1 more source
Targeting androgen receptor stability and degradation: approaches for developing a therapy for spinal and bulbar muscular atrophy. [PDF]
Cristofani R +16 more
europepmc +1 more source
Deubiquitinase USP7 contributes to the pathogenicity of spinal and bulbar muscular atrophy. [PDF]
Pluciennik A +12 more
europepmc +1 more source

